Bulletin
Investor Alert

press release

April 21, 2021, 4:48 a.m. EDT

Asthma Therapeutics Market Research Report by Drug Class, by Product, by Route of administration - Global Forecast to 2025 - Cumulative Impact of COVID-19

Asthma Therapeutics Market Research Report by Drug Class (Anti-inflammatory, Bronchodilators, and Combination therapy), by Product (Inhalers and Nebulizers), by Route of administration - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, April 21, Apr 21, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asthma Therapeutics Market Research Report by Drug Class, by Product, by Route of administration - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06062993/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Asthma Therapeutics Market is expected to grow from USD 18,403.69 Million in 2020 to USD 27,849.79 Million by the end of 2025.
2. The Global Asthma Therapeutics Market is expected to grow from EUR 16,136.70 Million in 2020 to EUR 24,419.22 Million by the end of 2025.
3. The Global Asthma Therapeutics Market is expected to grow from GBP 14,345.56 Million in 2020 to GBP 21,708.74 Million by the end of 2025.
4. The Global Asthma Therapeutics Market is expected to grow from JPY 1,964,140.07 Million in 2020 to JPY 2,972,278.30 Million by the end of 2025.
5. The Global Asthma Therapeutics Market is expected to grow from AUD 26,724.60 Million in 2020 to AUD 40,441.59 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Asthma Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Class, the Asthma Therapeutics Market studied across Anti-inflammatory, Bronchodilators, and Combination therapy.

Based on Product, the Asthma Therapeutics Market studied across Inhalers and Nebulizers. The Inhalers further studied across Dry powder inhalers, Metered-dose inhalers, and Soft mist inhalers.

Based on Route of administration, the Asthma Therapeutics Market studied across Inhaled and Oral.

Based on Geography, the Asthma Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Therapeutics Market including Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Biogen Inc., Boehringer Ingelheim GmbH, CareFusion Corporation, Convexity Scientific Inc, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Kare Medical and Analytical Devices Ltd. Co., Merck & Co. Inc., Merxin Ltd, Mylan N.V., Novartis AG, Parekhplast India Ltd, Philips Healthcare, Regeneron Pharmaceuticals, Inc, Roche Diagnostics, Sanofi-Aventis SA, Shenzhen Aeon Technology, Softhale NV, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Trudell Medical Limited (AeroEclipse), and Well Lead Medical Co.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Asthma Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Asthma Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Asthma Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Asthma Therapeutics Market?
Read the full report: https://www.reportlinker.com/p06062993/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________







        Clare: clare@reportlinker.com
        US: (339)-368-6001
        Intl: +1 339-368-6001
        


COMTEX_384805746/2471/2021-04-21T04:48:27

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

Partner Center

Link to MarketWatch's Slice.